Leukemia and Lymphoma Flashcards

1
Q

Definition of febrile neutropenia

A

WCC<2 or neutrophils<1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mx of febrile neutropenia (3)

A

low risk: ceftriaxone+blood cultures

medium: piptaz+gent+cultures

septic shock: vancomycin+meropenem+gent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RFs for ALL (2)

A

down’s

radiation

(does not run in families)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Features of ALL (4)

A

CNS involvement common

period before Dx consists of 2-4 wks of:

  • lymphadenopathy
  • anaemia, bleeding, infection
  • orchidomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classification of ALL (3)

A

morphological: L1/2/3

surface antigens:

  • B-cell precursor: most common
  • B Cell (B-lymphoblastic)
  • T cell (T-lymphoblastic)

chromosomal analysis:
-philadelphia=poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ix for ALL (8)

A

Raised WCC: lymphoblasts

CXR/CT: lymphadenopathy, lytic bone lesions and pneumonia

LP for CNS involvement:
-raised WCC w. blast forms

low platelets

normocytic anaemia

raised urate and LDH

marrow biopsy: 50-90% of nucleated cells are blasts

Common translocations:

  • TEL-AML: 12-21
  • philadelphia: 9-22
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mx of ALL (6)

A

supportive: bloods/platelets, fluids, allopurinol

insert SC port/hickman line for IV access

chemo:

  • induction: 3 drug induction+intrathecal methotrexate to induce remission
  • consolidation and CNS prophylaxis: cranial irradiation if known CNS disease
  • maintenance: daily mercaptopurine+weekly intrathecal methotrexate+vincristine/steroids. 3 months of intrathecal drugs. co-trimoxazole prophylaxis
  • imatinib if phil. +ve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Poor prognostic factors for ALL (4)

A

male

philadelphia Cr

CNS involvement

<1yr/>10yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Assoc. of AML (6)

A

Fanconi anaemia

Down’s

Edward’s

Li-Fraumeni

NF1

Osler-Weber-Rendu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RFs for AML (6)

A

chromosomal abnormalities-Down’s

radiation/chemicals (benzene)

chemotherapy

myelodysplastic syndromes

myeloproliferative syndromes

CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Features and presentation of acute promyelocytic anaemia (APML) (4)

A

pml-RARA fusion protein

DIC most common

gum hypertrophy

hepatosplenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ix for AML

A

marrow biopsy: auer rods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rx of AML (2)

A

all-trans-retinoic-acid (ATRA) for APML: poorer prognosis than AML

allogenic marrow transplant improves survival; may be offered if suitable donor found

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Presentation of lymphoma (4)

A

lymphadenopathy

mediastinal mass: SVC obs

Long Hx

B Sx rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Peak incidence and characteristic features of HL (2)

A

young and elderly

characterised by Reed-Sternberg cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

RFs for HL (5)

A

sibling affected

EBV

SLE

transplantation

obesity

17
Q

Presentation of HL (3)

A

painless, enlarged lymph nodes: may fluctuate in size. alcohol may bring pain

B-Sx

Guillan-Barre

18
Q

Ix for HL (2)

A

LN biopsy (not FNA):

  • nodular sclerosing: most common
  • lymphocyte predominant: best prognosis
  • lymphocyte depleted: worst prognosis
  • mixed cellularity

Bloods:

  • FBC
  • ESR
  • raised LDH
  • raised urate and Ca
19
Q

Staging of HL (4)

A

I: confined to single LN
II: two or more LNs on same side of diaphragm
III: two or more LNs on opposite sides of diaphragm
IV: extra-nodal spread

for each stage:
-A/B depending on B-Sx

20
Q

Mx and prognosis of HL (3)

A

RT+short course chemo

for relapses:
-high dose chemo+autologous SC transplant

prognosis better than NHL

21
Q

RFs for NHL (4)

A

chronic immune stimulation:

  • HIV
  • H-pylori
  • transplantation
  • HTLV-1

environmental carcinogens

congenital

radiation

22
Q

Presentation of NHL (5)

A

75% w. nodal disease

25% w. extra-nodal disease:

  • skin involvement e.g. sezary syndrome
  • oropharynx
  • gut: gastric MALT(h. pylori), non-MALT gastric lymphomas, small bowel.

B Sx more rare than in HL

23
Q

Ix for NHL (5)

A

Bloods: FBC, LFT, U+Es, LDH (raised LDH=poor prognosis)

LN/marrow biopsy for classification

XR/CT chest/abdo/pelvis for staging

cytology of any effusions

LP if CNS signs

24
Q

Classification of NHL (2)

A

low/high grade

25
Q

Features of low-grade NHL (4)

A

Follicular (18:14; B cell)

marginal zone lymphoma/MALT

lymphocytic lymphoma

lymphoplasmocytoid lymphoma (Waldenstrom’s)

26
Q

Features of high-grade NHL (4)

A

Diffuse large B cell: most common

lymphoblastic lymphoma

Burkitt’s: (8:14, IgH-Myc) assoc. w. EBV

T cell lymphomas

27
Q

Rx and criteria for Rx of low-grade NHL (5)

A

Rx if:

  • LNs causing blockage/pain
  • marrow failure
  • B Sx

localised radiotherapy can cure stage I/II

Chemo

28
Q

Rx of high-grad NHL

A

R-CHOP